Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grover

Showing results (11-20 of 391) with videos related to

Pageof 40
Sort By:
Cardiovascular Drugs and Therapy|November 1, 1993
Modifying serum lipids to prevent coronary heart disease: do we have a consensus?S A Grover
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 5, 2007
Volume-targeted ventilation in the neonate: time to change?A Grover, D Field
Irish Medical Journal|November 29, 2013
Chinese whispers in the post anaesthesia care unit (PACU)A Grover, E Duggan
European Journal of Immunology|June 1, 1986
Effect of liposomes on lymphocytes: induction of proliferation of B lymphocytes and potentiation of the cytotoxic response of T lymphocytes to alloantigensA Grover, G Sundharadas
Apoptosis : an International Journal on Programmed Cell Death|September 17, 2020
Maslinic acid differentially exploits the MAPK pathway in estrogen-positive and triple-negative breast cancer to induce mitochondrion-mediated, caspase-independent apoptosisR Jain, A Grover
The Journal of Emergency Medicine|October 11, 2011
Charles McBurney: McBurney's pointCasey A Grover, George Sternbach
Drug Safety|April 1, 1994
Risk-benefit assessment of drug treatment to prevent coronary heart disease. Estimating the benefits of risk factor modificationS A Grover, L Coupal
The Journal of Emergency Medicine|September 10, 2021
Aubrey Hampton and Benjamin Castleman: Hampton's HumpCasey A Grover, Justine How
Chest|July 1, 1991
Right atrial myxomaA Grover, P L Wahi
European Journal of Biochemistry|February 26, 2000
Characterization of a novel type VII beta-turn conformation for a bio-active tetrapeptide rigin A synergy between theoretical and experimental resultsAshish, A Grover, R Kishore
Pageof 40

Showing results (11-20 of 391) with videos related to

Sort By:
Pageof 40
Cardiovascular Drugs and Therapy|November 1, 1993
Modifying serum lipids to prevent coronary heart disease: do we have a consensus?S A Grover
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 5, 2007
Volume-targeted ventilation in the neonate: time to change?A Grover, D Field
Irish Medical Journal|November 29, 2013
Chinese whispers in the post anaesthesia care unit (PACU)A Grover, E Duggan
European Journal of Immunology|June 1, 1986
Effect of liposomes on lymphocytes: induction of proliferation of B lymphocytes and potentiation of the cytotoxic response of T lymphocytes to alloantigensA Grover, G Sundharadas
Apoptosis : an International Journal on Programmed Cell Death|September 17, 2020
Maslinic acid differentially exploits the MAPK pathway in estrogen-positive and triple-negative breast cancer to induce mitochondrion-mediated, caspase-independent apoptosisR Jain, A Grover
The Journal of Emergency Medicine|October 11, 2011
Charles McBurney: McBurney's pointCasey A Grover, George Sternbach
Drug Safety|April 1, 1994
Risk-benefit assessment of drug treatment to prevent coronary heart disease. Estimating the benefits of risk factor modificationS A Grover, L Coupal
The Journal of Emergency Medicine|September 10, 2021
Aubrey Hampton and Benjamin Castleman: Hampton's HumpCasey A Grover, Justine How
Chest|July 1, 1991
Right atrial myxomaA Grover, P L Wahi
European Journal of Biochemistry|February 26, 2000
Characterization of a novel type VII beta-turn conformation for a bio-active tetrapeptide rigin A synergy between theoretical and experimental resultsAshish, A Grover, R Kishore
Pageof 40